Cargando…

Temple syndrome in a patient with variably methylated CpGs at the primary MEG3/DLK1:IG-DMR and severely hypomethylated CpGs at the secondary MEG3:TSS-DMR

BACKGROUND: The human chromosome 14q32.2 imprinted region harbors the primary MEG3/DLK1:IG-differentially methylated region (DMR) and secondary MEG3:TSS-DMR. The MEG3:TSS-DMR can remain unmethylated only in the presence of unmethylated MEG3/DLK1:IG-DMR in somatic tissues, but not in the placenta, be...

Descripción completa

Detalles Bibliográficos
Autores principales: Kagami, Masayo, Yanagisawa, Atsuhiro, Ota, Miyuki, Matsuoka, Kentaro, Nakamura, Akie, Matsubara, Keiko, Nakabayashi, Kazuhiko, Takada, Shuji, Fukami, Maki, Ogata, Tsutomu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407230/
https://www.ncbi.nlm.nih.gov/pubmed/30846001
http://dx.doi.org/10.1186/s13148-019-0640-2
_version_ 1783401502872698880
author Kagami, Masayo
Yanagisawa, Atsuhiro
Ota, Miyuki
Matsuoka, Kentaro
Nakamura, Akie
Matsubara, Keiko
Nakabayashi, Kazuhiko
Takada, Shuji
Fukami, Maki
Ogata, Tsutomu
author_facet Kagami, Masayo
Yanagisawa, Atsuhiro
Ota, Miyuki
Matsuoka, Kentaro
Nakamura, Akie
Matsubara, Keiko
Nakabayashi, Kazuhiko
Takada, Shuji
Fukami, Maki
Ogata, Tsutomu
author_sort Kagami, Masayo
collection PubMed
description BACKGROUND: The human chromosome 14q32.2 imprinted region harbors the primary MEG3/DLK1:IG-differentially methylated region (DMR) and secondary MEG3:TSS-DMR. The MEG3:TSS-DMR can remain unmethylated only in the presence of unmethylated MEG3/DLK1:IG-DMR in somatic tissues, but not in the placenta, because of a hierarchical regulation of the methylation pattern between the two DMRs. METHODS: We performed molecular studies in a 4-year-old Japanese girl with Temple syndrome (TS14). RESULTS: Pyrosequencing analysis showed extremely low methylation levels of five CpGs at the MEG3:TSS-DMR and grossly normal methylation levels of four CpGs at the MEG3/DLK1:IG-DMR in leukocytes. HumanMethylation450 BeadChip confirmed marked hypomethylation of the MEG3:TSS-DMR and revealed multilocus imprinting disturbance (MLID) including mild hypomethylation of the H19/IGF2:IG-DMR and mild hypermethylation of the GNAS A/B:TSS-DMR in leukocytes. Bisulfite sequencing showed markedly hypomethylated CpGs at the MEG3:TSS-DMR and irregularly and non-differentially methylated CpGs at the MEG3/DLK1:IG-DMR in leukocytes and apparently normal methylation patterns of the two DMRs in the placenta. Maternal uniparental disomy 14 and a deletion involving this imprinted region were excluded. CONCLUSIONS: Such a methylation pattern of the MEG3/DLK1:IG-DMR has not been reported in patients with TS14. It may be possible that a certain degree of irregular hypomethylation at the MEG3/DLK1:IG-DMR has prevented methylation of the MEG3:TSS-DMR in somatic tissues and that a hypermethylation type MLID has occurred at the MEG3/DLK1:IG-DMR to yield the apparently normal methylation pattern in the placenta. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13148-019-0640-2) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6407230
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-64072302019-03-21 Temple syndrome in a patient with variably methylated CpGs at the primary MEG3/DLK1:IG-DMR and severely hypomethylated CpGs at the secondary MEG3:TSS-DMR Kagami, Masayo Yanagisawa, Atsuhiro Ota, Miyuki Matsuoka, Kentaro Nakamura, Akie Matsubara, Keiko Nakabayashi, Kazuhiko Takada, Shuji Fukami, Maki Ogata, Tsutomu Clin Epigenetics Short Report BACKGROUND: The human chromosome 14q32.2 imprinted region harbors the primary MEG3/DLK1:IG-differentially methylated region (DMR) and secondary MEG3:TSS-DMR. The MEG3:TSS-DMR can remain unmethylated only in the presence of unmethylated MEG3/DLK1:IG-DMR in somatic tissues, but not in the placenta, because of a hierarchical regulation of the methylation pattern between the two DMRs. METHODS: We performed molecular studies in a 4-year-old Japanese girl with Temple syndrome (TS14). RESULTS: Pyrosequencing analysis showed extremely low methylation levels of five CpGs at the MEG3:TSS-DMR and grossly normal methylation levels of four CpGs at the MEG3/DLK1:IG-DMR in leukocytes. HumanMethylation450 BeadChip confirmed marked hypomethylation of the MEG3:TSS-DMR and revealed multilocus imprinting disturbance (MLID) including mild hypomethylation of the H19/IGF2:IG-DMR and mild hypermethylation of the GNAS A/B:TSS-DMR in leukocytes. Bisulfite sequencing showed markedly hypomethylated CpGs at the MEG3:TSS-DMR and irregularly and non-differentially methylated CpGs at the MEG3/DLK1:IG-DMR in leukocytes and apparently normal methylation patterns of the two DMRs in the placenta. Maternal uniparental disomy 14 and a deletion involving this imprinted region were excluded. CONCLUSIONS: Such a methylation pattern of the MEG3/DLK1:IG-DMR has not been reported in patients with TS14. It may be possible that a certain degree of irregular hypomethylation at the MEG3/DLK1:IG-DMR has prevented methylation of the MEG3:TSS-DMR in somatic tissues and that a hypermethylation type MLID has occurred at the MEG3/DLK1:IG-DMR to yield the apparently normal methylation pattern in the placenta. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13148-019-0640-2) contains supplementary material, which is available to authorized users. BioMed Central 2019-03-07 /pmc/articles/PMC6407230/ /pubmed/30846001 http://dx.doi.org/10.1186/s13148-019-0640-2 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Short Report
Kagami, Masayo
Yanagisawa, Atsuhiro
Ota, Miyuki
Matsuoka, Kentaro
Nakamura, Akie
Matsubara, Keiko
Nakabayashi, Kazuhiko
Takada, Shuji
Fukami, Maki
Ogata, Tsutomu
Temple syndrome in a patient with variably methylated CpGs at the primary MEG3/DLK1:IG-DMR and severely hypomethylated CpGs at the secondary MEG3:TSS-DMR
title Temple syndrome in a patient with variably methylated CpGs at the primary MEG3/DLK1:IG-DMR and severely hypomethylated CpGs at the secondary MEG3:TSS-DMR
title_full Temple syndrome in a patient with variably methylated CpGs at the primary MEG3/DLK1:IG-DMR and severely hypomethylated CpGs at the secondary MEG3:TSS-DMR
title_fullStr Temple syndrome in a patient with variably methylated CpGs at the primary MEG3/DLK1:IG-DMR and severely hypomethylated CpGs at the secondary MEG3:TSS-DMR
title_full_unstemmed Temple syndrome in a patient with variably methylated CpGs at the primary MEG3/DLK1:IG-DMR and severely hypomethylated CpGs at the secondary MEG3:TSS-DMR
title_short Temple syndrome in a patient with variably methylated CpGs at the primary MEG3/DLK1:IG-DMR and severely hypomethylated CpGs at the secondary MEG3:TSS-DMR
title_sort temple syndrome in a patient with variably methylated cpgs at the primary meg3/dlk1:ig-dmr and severely hypomethylated cpgs at the secondary meg3:tss-dmr
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407230/
https://www.ncbi.nlm.nih.gov/pubmed/30846001
http://dx.doi.org/10.1186/s13148-019-0640-2
work_keys_str_mv AT kagamimasayo templesyndromeinapatientwithvariablymethylatedcpgsattheprimarymeg3dlk1igdmrandseverelyhypomethylatedcpgsatthesecondarymeg3tssdmr
AT yanagisawaatsuhiro templesyndromeinapatientwithvariablymethylatedcpgsattheprimarymeg3dlk1igdmrandseverelyhypomethylatedcpgsatthesecondarymeg3tssdmr
AT otamiyuki templesyndromeinapatientwithvariablymethylatedcpgsattheprimarymeg3dlk1igdmrandseverelyhypomethylatedcpgsatthesecondarymeg3tssdmr
AT matsuokakentaro templesyndromeinapatientwithvariablymethylatedcpgsattheprimarymeg3dlk1igdmrandseverelyhypomethylatedcpgsatthesecondarymeg3tssdmr
AT nakamuraakie templesyndromeinapatientwithvariablymethylatedcpgsattheprimarymeg3dlk1igdmrandseverelyhypomethylatedcpgsatthesecondarymeg3tssdmr
AT matsubarakeiko templesyndromeinapatientwithvariablymethylatedcpgsattheprimarymeg3dlk1igdmrandseverelyhypomethylatedcpgsatthesecondarymeg3tssdmr
AT nakabayashikazuhiko templesyndromeinapatientwithvariablymethylatedcpgsattheprimarymeg3dlk1igdmrandseverelyhypomethylatedcpgsatthesecondarymeg3tssdmr
AT takadashuji templesyndromeinapatientwithvariablymethylatedcpgsattheprimarymeg3dlk1igdmrandseverelyhypomethylatedcpgsatthesecondarymeg3tssdmr
AT fukamimaki templesyndromeinapatientwithvariablymethylatedcpgsattheprimarymeg3dlk1igdmrandseverelyhypomethylatedcpgsatthesecondarymeg3tssdmr
AT ogatatsutomu templesyndromeinapatientwithvariablymethylatedcpgsattheprimarymeg3dlk1igdmrandseverelyhypomethylatedcpgsatthesecondarymeg3tssdmr